Azienda Sanitaria Locale Cn2 Alba-Bra

Alba 9 trials 3 recruiting

9 Registered trials

3 Currently recruiting

Organisation

Azienda Sanitaria Locale Cn2 Alba-Bra

Location

Alba, Italy

Identifier

ORG-100048566

Address

Via Vida 10, 12051, Italy

Departments

[email protected]
Ginecologia Oncologica e Ostetricia
Medical oncology
Medicina Interna
Oncologia
Oncology
Ospedale Michele e Pietro Ferrero, SC Oncologia Via Tanaro 712060 Verduno
S.O.C. Oncologia
SC Oncologia

Clinical trials at this site (9)

Search interface

Progression under Olaparib: a randomized phaSE II trIal with docetaxel or carboplatin-docetaxel DOublet in mCRPC patieNts Pending

2023-503676-25-01 prostate cancer 4
A Phase II, Randomized, Trial of Niraparib Versus Best Supportive Careas Maintenance Treatment In Patients With Locally Advanced Or Metastat… Pending

2024-519519-32-00 urothelial cancer 4
Stereotactic body radiation therapy on Prostate with or without Androgen deprivation therapy, a phase III randomized controlled trial (SPA T… Pending

2024-520093-34-00 Acinar cell prostatic carcinoma 5
Phase 3 Study of INCB123667 Versus Investigator's Choice of Chemotherapy in Platinum Resistant Ovarian Cancer With Cyclin E1 Overexpression Pending

2025-522748-42-00 Ovarian cancer 5
Phase III study in mCRC patients with RAS/BRAF wild type tissue and RAS/BRAF mutated in LIquid BIopsy to compare in first-line therapy FOLFI… Recruiting

2024-517863-22-00 Study population consists in patients with a diagnosis 5 2024-12-01
"APalutamide and stEReotactic body radiation therapy for low burden metastatic hormone senSItive prostate cancer, a rANdomized trial -PERSIA… Recruiting

2022-501894-37-00 prostate cancer 4 2023-03-02
RAndomized, open label, multicenter study of Docetaxel versus an Androgen Receptor-targeted agent (abiraterone orenzalutamide) as first-line… Recruiting

2024-518623-30-00 metastatic castration resistant prostate cancer without 6 2020-10-01
A multicenter, randomized, open-label, blinded endpoint evaluation, phase 3 study comparing the effect of abelacimab relative to apixaban on… Ended

2023-509569-19-00 venous thromboembolism (VTE) 10 2022-08-10
Phase III, randomized, double-blind, placebo-controlled, multicenter study to evaluate the efficacy of pre-surgical HPV9-valente vaccination… Ended

2024-513704-34-00 cervical cancer 5 2021-10-01